DNMT3A and heart failure: This might be due to individual effects of the analysed sample, as previous GTEx [46] experiments showed no significant differences in expression of DNMT3A between atrial and ventricular tissue, and studies in mice revealed that deficiency of de novo CpG methylation capacity mediated by DNMT3A and DNMT3B was dispensable for pathological mechanisms in heart failure [47].